Skip to main content
. Author manuscript; available in PMC: 2020 Jan 2.
Published in final edited form as: J Anal Oncol. 2012;1(1):50–55. doi: 10.6000/1927-7229.2012.01.01.7

Figure 2:

Figure 2:

Proposed cholangiocarcinoma surveillance algorithm for patients with primary sclerosing cholangitis.

*Assumes stable findings. CA 19–9 and liver biochemistries to also be checked along with cholangiography. In addition, cytology and FISH to be checked with ERC.

**Consider early subspecialist referral if worsening in serum tests or other signs or symptoms.